Search results

32 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
NIAID grant launches Kashuba's plan for HIV-prevention trials
Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.
Located in Vital Signs / Archives / Vital Signs - Jan. 4, 2010
Moving clinical trials overseas tests the system’s safety, efficacy
Major U.S. drug companies are increasingly performing clinical trials in developing countries, raising serious concerns about the efficacy, ethics and economics of drug development, according to a study by two UNC researchers in the current issue of the New England Journal of Medicine.
Located in Vital Signs / 2009 / February
UNC Health Workers Called to Join National PCORnet® Study to Fight COVID-19
The HeroesResearch.org clinical research registry is designed to answer crucial questions about the impact of novel coronavirus on health care workers’ lives, and includes a multi-site clinical trial of hydroxychloroquine led at UNC by Ross Boyce, MD, assistant professor of medicine.
Located in News / 2020 / April
Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit
In a clinical trial of an experimental drug to treat thyroid cancer, UNC and six other institutions report the first evidence in this tumor that targeting therapy to an oncogene documented to be present in the patient receiving therapy may be associated with clinical benefit. Neil Hayes, MD, is the UNC principal investigator and first author of the study.
Located in Vital Signs / 2012 / April 12
Moderate weight loss helps reduce risk of osteoarthritis in the knee
Maintaining weight provides no benefit, UNC study shows
Located in Vital Signs / Archives / Vital Signs - Nov. 5, 2009
UNC seeking participants for anorexia nervosa couples therapy trial
Developed by the UNC School of Medicine Eating Disorders Program and funded by the National Institute of Mental Health, Uniting Couples (in the treatment of) Anorexia Nervosa, or UCAN, is the first and only NIH-funded trial of treatment for anorexia that emphasizes couple therapy.
Located in Vital Signs / 2009 / February
NIAID grant launches Kashuba's plan for HIV-prevention trials
Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.
Located in Vital Signs / 2010 / Vital Signs - Jan. 4, 2010
UNC selected to participate in new trial for patients with uncontrolled hypertension - Symplicity HTN-3
This is a randomized, controlled trial to evaluate the efficacy and safety of percutaneous renal denervation in patients with uncontrolled hypertension. Drs. Rick Stouffer and Alan Hinderliter are the Co-PIs at the UNC site, with collaborating investigators from the Division of Nephrology and Hypertension and the Department of Family Medicine.
Located in Vital Signs / 2012 / Feb. 16
Moderate weight loss helps reduce risk of osteoarthritis in the knee
Maintaining weight provides no benefit, UNC study shows
Located in Vital Signs / 2009 / Vital Signs - Nov. 5, 2009
UNC Researchers Dramatically Reduce Racial Disparities in Early-Stage Lung Cancer Treatment
UNC School of Medicine’s Samuel Cykert, MD, in the department of medicine, led a five-year, multi-institutional trial aimed at reducing the disparity in treatment and outcomes for black lung cancer patients versus white lung cancer patients.
Located in News / 2019 / February